Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-060286

General Counsel sold 1,200 shares at $27.36 ($32,832)

  • General Counsel acquired 1,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-11 Exercise or conversion : show line 1 in the form +1,200 $1.86 $2,232 2,486 D
2021-10-11 Sale : show line 2 in the form −1,200 $27.36 $32,832 1,286 D
Open-market sales · 1,200 sh · avg $27.36 · $32,832

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-11 Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) −1,200 104,466 D
Loading xslF345X03/doc4.xml…